Are the kind of medications and patient's background associated with improving polypharmacy in elderly?

about

Are the kind of medications and patient's background associated with improving polypharmacy in elderly?

Item

http://www.wikidata.org/entity/Q59125378

description

scientific article published on 22 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Are the kind of medications an ...... oving polypharmacy in elderly?

@en

Are the kind of medications an ...... oving polypharmacy in elderly?

@nl

type

Item

label

Are the kind of medications an ...... oving polypharmacy in elderly?

@en

Are the kind of medications an ...... oving polypharmacy in elderly?

@nl

prefLabel

Are the kind of medications an ...... oving polypharmacy in elderly?

@en

Are the kind of medications an ...... oving polypharmacy in elderly?

@nl

P1476

Are the kind of medications an ...... oving polypharmacy in elderly?

@en

P2093

Daiki Kobayashi

http://www.w3.org/2001/XMLSchema#string

Hiroko Arioka

http://www.w3.org/2001/XMLSchema#string

Kuniyoshi Hayashi

http://www.w3.org/2001/XMLSchema#string

P2860

Predicting Anatomical Therapeutic Chemical (ATC) classification of drugs by integrating chemical-chemical interactions and similarities

Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study

Obesity: preventing and managing the global epidemic. Report of a WHO consultation

Adverse drug events are a major cause of acute medical admission.

Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.

Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.

STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation.

Incidence and preventability of adverse drug events among older persons in the ambulatory setting.

Optimising drug treatment for elderly people: the prescribing cascade

P304

205-210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JGF2.207

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shiori Tomita

P577

2018-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30464867

http://www.w3.org/2001/XMLSchema#string

P932

6238230

http://www.w3.org/2001/XMLSchema#string